Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2017 by Georgetown University
Sponsor:
Collaborator:
Abbott
Information provided by (Responsible Party):
Georgetown University
ClinicalTrials.gov Identifier:
NCT01489865
First received: December 8, 2011
Last updated: March 30, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)